HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey E Saffitz Selected Research

gamma Catenin (Plakoglobin)

2/2016Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells.
9/2013Reduced plakoglobin immunoreactivity in arrhythmogenic cardiomyopathy: methodological considerations.
3/2013Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy.
10/2011Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.
4/2011Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutations.
3/2009A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy.
11/2007A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.
9/2006Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy.
6/2005Dependence of electrical coupling on mechanical coupling in cardiac myocytes: insights gained from cardiomyopathies caused by defects in cell-cell connections.
5/2004Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey E Saffitz Research Topics

Disease

23Cardiomyopathies (Cardiomyopathy)
01/2021 - 01/2004
11Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy)
11/2014 - 05/2004
9Heart Failure
01/2020 - 02/2002
4Myocardial Ischemia (Ischemic Heart Diseases)
08/2007 - 06/2002
3Inflammation (Inflammations)
01/2020 - 10/2011
3Fibrosis (Cirrhosis)
01/2020 - 09/2006
3Heart Diseases (Heart Disease)
11/2019 - 08/2007
3Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2018 - 11/2012
3Cardiac Sudden Death (Sudden Cardiac Arrest)
11/2012 - 11/2003
3Ischemia
09/2007 - 05/2003
2Necrosis
01/2021 - 10/2019
2Atrial Fibrillation
01/2020 - 06/2006
2Cicatrix (Scar)
01/2019 - 02/2003
2Sarcoidosis (Schaumann Disease)
08/2013 - 10/2011
2Myocarditis (Carditis)
08/2013 - 10/2011
2Ventricular Tachycardia
08/2012 - 06/2003
2Sudden Death
01/2012 - 08/2009
2Naxos disease
11/2007 - 05/2004
2Myocardial Infarction
02/2003 - 06/2002
1Hypertrophy
01/2020
1Ventricular Remodeling
01/2020
1Ectodermal Dysplasia (Aplasia Cutis Congenita)
01/2020
1Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
01/2020
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
08/2013
1Crohn Disease (Crohn's Disease)
08/2013
1Tuberculosis (Tuberculoses)
08/2013
1Sudden Infant Death (SID)
01/2012
1Desmin-Related Myofibrillar Myopathy
08/2010
1Skin Diseases (Skin Disease)
05/2009
1Infections
09/2007
1Atherosclerotic Plaque (Atheroma)
12/2005
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
07/2004
1Amyloidosis
07/2004
1Left Ventricular Dysfunction
05/2004
1Cardiomegaly (Heart Hypertrophy)
04/2004
1Restrictive Cardiomyopathy
04/2004

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
10/2019 - 06/2003
15Connexin 43 (Connexin43)IBA
01/2020 - 02/2002
10gamma Catenin (Plakoglobin)IBA
02/2016 - 05/2004
9ConnexinsIBA
01/2020 - 11/2003
7Desmoplakins (Desmoplakin)IBA
01/2020 - 01/2004
3DesminIBA
08/2010 - 07/2004
2Biomarkers (Surrogate Marker)IBA
01/2020 - 12/2005
2ParaffinIBA
01/2020 - 01/2012
2CytokinesIBA
10/2019 - 10/2011
2phospholambanIBA
05/2019 - 11/2012
2Pharmaceutical PreparationsIBA
02/2016 - 12/2014
2Desmoglein 2IBA
10/2010 - 09/2006
1Galectin 3 (LGALS3)IBA
01/2021
1Cyclophilin AIBA
01/2021
1Peptides (Polypeptides)IBA
01/2021
1calpastatinIBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2020
1Formaldehyde (Formol)FDA Link
01/2020
1GlutamatesIBA
01/2020
1GlycogenIBA
01/2020
1D-Aspartic Acid (D Aspartate)IBA
01/2020
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2020
1Trans-Activators (Trans-Acting Factor)IBA
01/2020
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2020
1TOR Serine-Threonine KinasesIBA
01/2020
1Serine (L-Serine)FDA Link
01/2020
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
11/2019
13- (4- methylphenylsulfonyl)- 2- propenenitrileIBA
10/2019
1Glycogen Synthase (Synthase I)IBA
05/2019
1Discs Large Homolog 1 ProteinIBA
05/2019
1FilaminsIBA
01/2018
1Phosphotransferases (Kinase)IBA
02/2016
1Transcription Factors (Transcription Factor)IBA
02/2016
1SB 216763IBA
06/2014
1Cathepsin KIBA
08/2013
1Sodium Channels (Sodium Channel)IBA
03/2013
1DNA (Deoxyribonucleic Acid)IBA
01/2012
1InterleukinsIBA
10/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2011
1CateninsIBA
10/2011
1Interleukin-6 (Interleukin 6)IBA
10/2011
1Cadherins (E-Cadherin)IBA
10/2010
1Complement System Proteins (Complement)IBA
09/2007
1LipidsIBA
09/2006
1PlakophilinsIBA
09/2006
1AcidsIBA
08/2005
1Small Heat-Shock ProteinsIBA
07/2004
1alpha-Crystallin B ChainIBA
07/2004
1Amyloid (Amyloid Fibrils)IBA
07/2004
1Cell Adhesion MoleculesIBA
05/2004
1salicylhydroxamic acid (SHAM)IBA
05/2004
1Muromonab-CD3 (Muromonab CD3)FDA Link
05/2004
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2004
1SteroidsIBA
05/2004
1Thomsen-Friedenreich antibodiesIBA
05/2004
1JNK Mitogen-Activated Protein KinasesIBA
04/2004
1Protein Kinase CIBA
04/2004
1PPAR gammaIBA
03/2004

Therapy/Procedure

4Heart Transplantation (Grafting, Heart)
10/2015 - 05/2004
3Therapeutics
02/2016 - 02/2003
3Ligation
05/2004 - 06/2002
1Radiofrequency Ablation
01/2019
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
11/2012
1Plasmapheresis
05/2004